Cargando…
Metabolomic analysis of serum may refine 21-gene expression assay risk recurrence stratification
Despite recent refinements to the 21-gene g score, allowing a better identification of patients who may derive no benefit from the addition of adjuvant chemotherapy to that of endocrine therapy, patients with early breast cancer still stand to be over-treated in the setting of clinical and/or genomi...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715716/ https://www.ncbi.nlm.nih.gov/pubmed/31482106 http://dx.doi.org/10.1038/s41523-019-0123-9 |